Analyze Diet
Frontiers in veterinary science2019; 6; 265; doi: 10.3389/fvets.2019.00265

Treatment of Infiltrative Superficial Tumors in Awake Standing Horses Using Novel High-Frequency Pulsed Electrical Fields.

Abstract: Irreversible electroporation is a proven ablation modality for local ablation of soft tissue tumors in animals and humans. However, the strong muscle contractions associated with the electrical impulses (duration, 50-100 μs) requires the use of general anesthesia and, in most situations, application of neuromuscular blockade. As such, this technology is not used in an outpatient setting for ablating common cutaneous tumors (e.g., squamous cell carcinoma or melanoma) in humans or animals. Recently, high-frequency irreversible electroporation (H-FIRE) technology has been developed to enable electroporation of tumors without stimulation of nearby skeletal muscle. H-FIRE administers bursts of electrical pulses (duration, 0.5-2 μs) through bipolar electrodes placed in tumor parenchyma. We hypothesized that H-FIRE could be used to safely ablate superficial tumors in standing, awake horses without the need for general anesthesia. Here, we describe the treatment of superficial tumors in five horses using this novel ablation therapy without the need for general anesthesia. In each case, H-FIRE therapy predictably ablated tumor volume. All patients tolerated the procedure, no complications developed, and veterinary personnel safety was maintained. The H-FIRE treatment may be useful for treatment in veterinary and human patients in an outpatient setting without the need for hospitalization, general anesthesia, and advanced monitoring techniques.
Publication Date: 2019-08-14 PubMed ID: 31475163PubMed Central: PMC6705183DOI: 10.3389/fvets.2019.00265Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article investigates the use of a novel high-frequency pulsed electrical fields (H-FIRE) technology to safely remove superficial tumors in standing, awake horses without needing general anesthesia.

Background of the Study

  • The researchers focused on testing a method of tumor removal known as irreversible electroporation, which is recognized for its effectiveness in both animals and humans in local removal of soft tissue tumors.
  • One of the main challenges of traditional irreversible electroporation is that it often stimulates strong muscle contractions due to the electrical impulses it produces. This usually necessitates the use of general anesthesia and neuromuscular blockade.
  • Because of these requirements, this technology cannot be conveniently used in an outpatient setting to ablate common skin tumors in patients, whether human or animal.

The New High-Frequency Irreversible Electroporation (H-FIRE) Technology

  • The high-frequency irreversible electroporation (H-FIRE) technology has been developed to help bypass the limitations of the traditional irreversible electroporation method.
  • H-FIRE uses short bursts of electrical pulses delivered through bipolar electrodes placed in tumor tissue, allowing for the electroporation of tumors without stimulating the nearby skeletal muscle.
  • The short duration of the electrical pulses (0.5 to 2 microseconds) makes it more feasible for use on patients without subjecting them to general anesthesia.

Study Method and Findings

  • In this study, the H-FIRE technique was used to treat superficial tumors in five awake, standing horses, keeping away the need for general anesthesia.
  • The results of the study showed that not only could H-FIRE dependably ablate tumor volume in each case, but all horses also tolerated the procedure well, no complications arose, and the safety of the veterinary personnel was ensured throughout the process.

Implications of the Study

  • This research indicates that H-FIRE could potentially be a beneficial treatment for both veterinary and human patients in an outpatient setting, without requiring hospitalization, general anesthesia, or advanced monitoring techniques.
  • The successful application of this technology could revolutionize how superficial tumors are treated, making the process more comfortable for the patient and easier to administer for healthcare providers.

Cite This Article

APA
Byron CR, DeWitt MR, Latouche EL, Davalos RV, Robertson JL. (2019). Treatment of Infiltrative Superficial Tumors in Awake Standing Horses Using Novel High-Frequency Pulsed Electrical Fields. Front Vet Sci, 6, 265. https://doi.org/10.3389/fvets.2019.00265

Publication

ISSN: 2297-1769
NlmUniqueID: 101666658
Country: Switzerland
Language: English
Volume: 6
Pages: 265

Researcher Affiliations

Byron, Christopher R
  • Department of Large Animal Clinical Sciences, Virginia-Maryland Regional College of Veterinary Medicine, Virginia Tech, Blacksburg, VA, United States.
DeWitt, Matthew R
  • Virginia Tech-Wake Forest School of Biomedical Engineering and Science, College of Engineering, Virginia Tech, Blacksburg, VA, United States.
Latouche, Eduardo L
  • Virginia Tech-Wake Forest School of Biomedical Engineering and Science, College of Engineering, Virginia Tech, Blacksburg, VA, United States.
Davalos, Rafael V
  • Virginia Tech-Wake Forest School of Biomedical Engineering and Science, College of Engineering, Virginia Tech, Blacksburg, VA, United States.
Robertson, John L
  • Virginia Tech-Wake Forest School of Biomedical Engineering and Science, College of Engineering, Virginia Tech, Blacksburg, VA, United States.

References

This article includes 24 references
  1. Robertson J. Diseases of the integumentary system.. (1996) p. 287–307.
  2. Robertson JL. Lymphosarcoma and other rare skin tumors.. (1997) p. 187–97.
  3. Cemazar M, Tamzali Y, Sersa G, Tozon N, Mir LM, Miklavcic D. Electrochemotherapy in veterinary oncology.. J Vet Intern Med (2008) 22:826–31.
  4. Souza C, Villarino NF, Farnsworth K, Black ME. Enhanced cytotoxicity of bleomycin, cisplatin, and carboplatin on equine sarcoid cells following electroporation-mediated deliver in vitro.. Vet Pharm Ther (2016) 40:97–100.
    doi: 10.1111/jvp.12331pubmed: 27287308google scholar: lookup
  5. Tamzali Y, Teissie J, Golzio M, Rols MP. Electrochemotherapy of equine cutaneous tumors: a 57 case retrospective study 1999-2005.. IFMBE Proceedings Vol. 16 Berlin; Heidelberg: Springer; (2007) p. 610–3.
  6. Tamzali Y, Borde L, Rols MP, Golzio M, Lyazrhi F, Teissie J. Successful treatment of equine sarcoids with cisplatin electrochemotherapy: a retrospective study of 48 cases.. Equine Vet J (2012) 44:214–20.
  7. Tozon N, Kramaric P, Kos Kadunc V, Sersa G, Cemazar M. Electrochemotherapy as a single treatment or adjuvant treatment to surgery of cutaneous sarcoid tumors in horses: a 31-case retrospective study.. Vet Rec (2016) 179:627.
    doi: 10.1136/vr.103867pubmed: 27758950google scholar: lookup
  8. Spugnini EP, D'Alterio GL, Eng ID, Eng TM, Dragonetti E, Murace R. Electrochemotherapy for the treatment of multiple melanomas in a horse.. J Equine Vet Sci (2011) 31:430–3.
  9. Miklavcic D, Pucihar G, Pavlovec M, Ribaric S, Mali M, Macek-Lebar A. The effect of high frequency electric pulses on muscle contractions and antitumor efficacy in vivo for a potential use in clinical electrochemotherapy.. Bioelectrochemistry (2005) 65:121–8.
  10. Davalos RV, Mir LM, Rubinsky B. Tissue ablation with irreversible electroporation.. Ann Biomed Eng (2005) 33:223–1.
    doi: 10.1007/s10439-005-8981-8pubmed: 15771276google scholar: lookup
  11. Yarmush ML, Golberg A, Sersa G, Kotnik T, Miklavcic D. Electroporation-based technologies for medicine: principles, applications, and challenges.. Ann Rev Biomed Eng (2014) 16:295–320.
  12. Martin RC II, McFarland K, Ellis S, Velanovich V. Irreversible electroporation in locally advanced pancreatic cancer: potential improved overall survival.. Ann Surg Oncol (2013) 20:443–9.
    doi: 10.1245/s10434-012-2736-1pubmed: 23128941google scholar: lookup
  13. Arena CB, Sano MB, Rossmeisl JH Jr, Caldwell JL, Garcia PA, Rylander MN. High-frequency irreversible electroporation (H-FIRE) for non-thermal ablation without muscle contraction.. Biomed Eng online (2011) 10:102.
    doi: 10.1186/1475-925X-10-102pmc: PMC3258292pubmed: 22104372google scholar: lookup
  14. Latouche EL, Arena CB, Ivey JW, Garcia PA, Pancotto TE, Pavlisko N. High-frequency irreversible electroporation for intracranial meningioma: a feasibility study in a spontaneous canine tumor model.. Technol Cancer Res Treat (2018) 17:1–10.
    doi: 10.1177/1533033818785285pmc: PMC6077896pubmed: 30071778google scholar: lookup
  15. Jiang CL, Davalos RV, Bischof JC. A review of basic to clinical studies of irreversible electroporation therapy.. IEEE Trans Biomed Eng (2015) 62:4–20.
    doi: 10.1109/TBME.2014.2367543pubmed: 25389236google scholar: lookup
  16. Valentine BA. Equine melanocytic tumors: a retrospective study of 53 horses (1988 to 1991).. J Vet Intern Med (1995) 9:291–7.
  17. Johnson PJ. Dermatologic tumors of horses (excluding sarcoids).. Vet Clin North Am Equine Pract (1998) 14:625–58, viii.
    doi: 10.1016/S0749-0739(17)30190-6pubmed: 9891728google scholar: lookup
  18. Marti E, Lazary S, Antczak DF, Gerber H. Report of the first international workshop on equine sarcoid.. Equine Vet J (1993) 25:397–407.
  19. Knottenbelt DC, Kelly DF. The diagnosis and treatment of periorbital sarcoid in the horse: 445 cases from 1974-1999.. Vet Ophthalmol (2000) 3:169–191.
  20. Cockerell GL, MacCoy DM. Clinicopathological manifestations of selected neoplasms.. Cornell Vet (1978) 68:133–50.
    pubmed: 204450
  21. Elbahi A, Kipar A, Ressel L. Histocytic-like atypicsl mast cell tumours in horses.. J Comp Pathol (2018) 162:14–17.
    doi: 10.1016/j.jcpa.2018.05.003pubmed: 30060838google scholar: lookup
  22. Kodre V, Cemazar M, Pecar J, Sersa G, Cor A, Tozon N. Electrochemotherapy compared to surgery for treatment of canine mast cell tumors.. In Vivo (2009) 23:55–62.
    pubmed: 19368125
  23. Senior JM. Morbidity, mortality, and risk of general anesthesia in horses.. Vet Clin North Am Equine Pract (2013) 29:1–18.
    doi: 10.1016/j.cveq.2012.11.007pubmed: 23498043google scholar: lookup
  24. Golberg A, Rubinsky B. Towards electroporation based treatment planning considering electric field induced muscle contractions.. Technol Cancer Res Treat (2012) 11:189–201.
    doi: 10.7785/tcrt.2012.500249pubmed: 22335414google scholar: lookup